Ingo H. Engels

12.0k citations

23 papers · 2.7k indexed · 1 hit paper · h-index 19

Molecular Biology top 5%
Physiology top 2%
Immunology top 5%
Oncology top 10%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Klaus Schulze‐Osthoff Sebastian Wesselborg Reiner U. Jänicke Marek Łoś Kirsten Lauber Christoph P. Berg Christopher Stroh Quinn L. Deveraux
Topics: Cell death mechanisms and regulation (11 papers)DNA Repair Mechanisms (4 papers)RNA Interference and Gene Delivery (3 papers)
Cited by: Physiology Molecular Biology Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Blood
Partner nations: Germany United States Singapore

In The Last Decade

Ingo H. Engels

23 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemical activation of the mechanotransduction channel Piezo1

2015 487 citations Ruhma Syeda, Jie Xu et al. eLife profile →

Peers

Countries citing papers authored by Ingo H. Engels

Since Specialization

Citations

This map shows the geographic impact of Ingo H. Engels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo H. Engels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo H. Engels more than expected).

Fields of papers citing papers by Ingo H. Engels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo H. Engels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo H. Engels. The network helps show where Ingo H. Engels may publish in the future.

Co-authorship network of co-authors of Ingo H. Engels

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo H. Engels. A scholar is included among the top collaborators of Ingo H. Engels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo H. Engels. Ingo H. Engels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemical activation of the mechanotransduction channel Piezo1breakdown → 2015 ·eLife ·Ruhma Syeda,Jie Xu,Adrienne E. Dubin,Bertrand Coste,Jayanti Mathur,Truc T. Huynh,Jason Matzen,Jianmin Lao,David C. Tully,Ingo H. Engels,H. Michael Petrassi,Andrew M. Schumacher,M Montal,Michael Bandell,Ardem Patapoutian	487
2	A biochemical screen for GroEL/GroES inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Johnson,(unknown),Puiying A. Mak,(unknown),Ingo H. Engels,Achim Brinker,Peter G. Schultz,Arthur L. Horwich,Eli Chapman	34
3	Small molecule inhibitors of trans -translation have broad-spectrum antibiotic activity 2013 ·Proceedings of the National Academy of Sciences ·Nitya S. Ramadoss,John N. Alumasa,Lin Cheng,Yu Wang,Sharon Li,Benjamin S. Chambers,(unknown),Arnab K. Chatterjee,Achim Brinker,Ingo H. Engels,Kenneth C. Keiler	63
4	HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1 2010 ·PubMed ·(unknown),Leonardo Vargas,(unknown),Michael Garcia,Yury J. Sigal,(unknown),Christian Schmedt,Jeremy S. Caldwell,Achim Brinker,Ingo H. Engels	16
5	A time-resolved fluorescence resonance energy transfer-based assay for DEN1 peptidase activity 2009 ·Analytical Biochemistry ·Ingo H. Engels,(unknown),Truc T. Huynh,Hugo D. Urbina,Joerg Buddenkotte,Andrew Schumacher,Jeremy S. Caldwell,Achim Brinker	16
6	Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening 2009 ·PLoS ONE ·(unknown),(unknown),Paul Anderson,Buu P. Tu,Genevieve Welch,Yingyao Zhou,Jeremy S. Caldwell,Ingo H. Engels,Achim Brinker	30
7	Agonists of Proteinase-Activated Receptor-2 Stimulate Upregulation of Intercellular Cell Adhesion Molecule-1 in Primary Human Keratinocytes via Activation of NF-kappa B 2005 ·Journal of Investigative Dermatology ·Joerg Buddenkotte,Christopher Stroh,Ingo H. Engels,(unknown),Victoria Shpacovitch,Stephan Seeliger,Nathalie Vergnolle,Dietmar Vestweber,Thomas A. Luger,Klaus Schulze‐Osthoff,Martin Steinhoff	110
8	Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway 2004 ·Cancer Cell ·Yan Wang,Ingo H. Engels,Deborah Knee,Marc Nasoff,Quinn L. Deveraux,Kim Quon	131
9	Transcription factor AP-2α triggers apoptosis in cardiac myocytes 2004 ·Cell Death and Differentiation ·Frank U. Müller,Karin Loser,(unknown),Joachim Neumann,Christian von Wallbrunn,Thomas Dobner,HH Scheld,Heike Bantel,Ingo H. Engels,Klaus Schulze‐Osthoff,Wilhelm Schmitz	17
10	Apoptosis Resistance of MCF-7 Breast Carcinoma Cells to Ionizing Radiation Is Independent of p53 and Cell Cycle Control but Caused by the Lack of Caspase-3 and a Caffeine-Inhibitable Event 2004 ·Cancer Research ·Frank Eßmann,Ingo H. Engels,Gudrun Totzke,Klaus Schulze‐Osthoff,Reiner U. Jänicke	94
11	Caspase-2 Can Function Upstream of Bid Cleavage in the TRAIL Apoptosis Pathway 2004 ·Journal of Biological Chemistry ·Klaus W. Wagner,Ingo H. Engels,Quinn L. Deveraux	98
12	Staphylococcus aureus α-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation 2003 ·Cell Death and Differentiation ·Frank Eßmann,Heike Bantel,Gudrun Totzke,Ingo H. Engels,Bhanu Sinha,Klaus Schulze‐Osthoff,Reiner U. Jänicke	101
13	Tributyltin (TBT) induces ultra-rapid caspase activation independent of apoptosome formation in human platelets 2003 ·Oncogene ·Christoph P. Berg,(unknown),Kirsten Lauber,Gerburg M. Stein,Ingo H. Engels,Claus Belka,Reiner U. Jänicke,Klaus Schulze‐Osthoff,Sebastian Wesselborg	11
14	Expression of Calcium-Binding Proteins MRP8 and MRP14 in Inflammatory Muscle Diseases 2003 ·American Journal Of Pathology ·Stephan Seeliger,Thomas Vogl,Ingo H. Engels,J. M. Schröder,Clemens Sorg,Cord Sunderkötter,Johannes Roth	68
15	Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells 2001 ·Oncogene ·Reiner U. Jänicke,Ingo H. Engels,Torsten Dunkern,Bernd Kaina,Klaus Schulze‐Osthoff,Alan G. Porter	71
16	Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation 2001 ·Oncogene ·Anna Stępczyńska,Kirsten Lauber,Ingo H. Engels,Ottmar Janßen,Dieter Kabelitz,Sebastian Wesselborg,Klaus Schulze‐Osthoff	133
17	Caspases: more than just killers? 2001 ·Trends in Immunology ·Marek Łoś,Christopher Stroh,Reiner U. Jänicke,Ingo H. Engels,Klaus Schulze‐Osthoff	148
18	Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis 2001 ·Cell Death and Differentiation ·Christoph P. Berg,Ingo H. Engels,(unknown),Kirsten Lauber,Andrea Renz,Stephan Schlösser,Klaus Schulze‐Osthoff,Sebastian Wesselborg	316
19	Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis 2000 ·Oncogene ·Ingo H. Engels,(unknown),Christopher Stroh,Kirsten Lauber,Christoph P. Berg,(unknown),Harald Wajant,Reiner U. Jänicke,Alan G. Porter,Claus Belka,Michael Gregor,Klaus Schulze‐Osthoff,Sebastian Wesselborg	231
20	Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. 1999 ·PubMed ·Heike Bantel,Ingo H. Engels,Wolfgang Voelter,Klaus Schulze‐Osthoff,Sebastian Wesselborg	169

About Ingo H. Engels

Ingo H. Engels is a scholar working on Molecular Biology, Oncology and Immunology, having authored 23 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), DNA Repair Mechanisms (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Physiology (786 citations), Molecular Biology (1.9k citations) and Immunology (477 citations). Ingo H. Engels has collaborated with scholars based in Germany, United States and Singapore. Frequent co-authors include Klaus Schulze‐Osthoff, Sebastian Wesselborg, Reiner U. Jänicke, Marek Łoś, Kirsten Lauber, Christoph P. Berg, Christopher Stroh, Quinn L. Deveraux, Heike Bantel and Gudrun Totzke. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact